We are live on ! Find out more
CAH icon

Cardinal Health

718 hedge funds and large institutions have $11.6B invested in Cardinal Health in 2018 Q4 according to their latest regulatory filings, with 131 funds opening new positions, 202 increasing their positions, 281 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $110M | Put options by funds: $71.5M

49% more first-time investments, than exits

New positions opened: 131 | Existing positions closed: 88

5% more funds holding

Funds holding: 685718 (+33)

0.75% more ownership

Funds ownership: 87.23%87.97% (+0.75%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

20% less capital invested

Capital invested by funds: $14.5B → $11.6B (-$2.9B)

28% less repeat investments, than reductions

Existing positions increased: 202 | Existing positions reduced: 281

Holders
718
Holders Change
+33
Holders Change %
+4.82%
% of All Funds
16%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
131
Increased
202
Reduced
281
Closed
88
Calls
$110M
Puts
$71.5M
Net Calls
+$38.7M
Net Calls Change
+$51M
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
226
Riverhead Capital Management
Delaware
$2.41M -$587K -11,256 -17%
Skandinaviska Enskilda Banken (SEB)
227
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.4M -$290K -5,564 -9%
HIMCH
228
Hartford Investment Management Co (HIMCO)
Connecticut
$2.39M -$79.3K -1,521 -3%
XK
229
Xact Kapitalforvaltning
Sweden
$2.38M -$369K -7,073 -12%
HighTower Advisors
230
HighTower Advisors
Illinois
$2.37M -$1.58M -30,324 -36%
ERSOT
231
Employees Retirement System of Texas
Texas
$2.36M -$2.03M -38,947 -42%
Victory Capital Management
232
Victory Capital Management
Texas
$2.28M -$58.2K -1,116 -2%
CCM
233
Cullen Capital Management
New York
$2.23M +$2.61M +50,030 New
GH
234
GAM Holding
Switzerland
$2.21M +$1.28M +24,631 +99%
CB
235
Cadence Bank
Mississippi
$2.2M +$91.8K +1,761 +4%
FCM
236
Flinton Capital Management
Pennsylvania
$2.19M -$527K -10,112 -17%
ACM
237
Advisors Capital Management
New Jersey
$2.15M -$238K -4,564 -9%
MCP
238
Martin Capital Partners
Oregon
$2.11M +$2.46M +47,254 New
LIA
239
LS Investment Advisors
Michigan
$2.07M -$164K -3,143 -6%
FI
240
Fosun International
China
$2.06M -$1.89M -36,184 -44%
RC
241
Reik & Co
New York
$2.06M
NMIMC
242
Northwestern Mutual Investment Management Company
Wisconsin
$2.02M -$454K -8,715 -16%
AIM
243
Achmea Investment Management
Netherlands
$1.98M -$195K -3,737 -8%
SCA
244
Secor Capital Advisors
New York
$1.94M +$1.92M +36,779 +544%
MLICM
245
Metropolitan Life Insurance Company (MetLife)
New York
$1.93M -$93.9K -1,801 -4%
ECM
246
ETrade Capital Management
Virginia
$1.93M -$57K -1,093 -2%
OIM
247
Orca Investment Management
Oregon
$1.92M +$2.25M +43,099 New
CGH
248
Crossmark Global Holdings
Texas
$1.92M -$71.6K -1,373 -3%
LS
249
Livforsakringsbolaget Skandia
Sweden
$1.91M
SCM
250
Southport Capital Management
Tennessee
$1.9M +$1.2M +22,930 +117%

CAH Hedge Fund Activity: Q4 2018 in Review

718 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q4 2018, worth a combined $11.6B — down 20% from $14.5B a quarter earlier.

Buyers outnumbered sellers: 131 funds opened new CAH positions and 88 closed out — a net gain of 43 holders — while 202 added to existing stakes and 281 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $124M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $454M.

  • 718 institutional investors held Cardinal Health (CAH) as of Q4 2018, up from 685 in Q3 2018.
  • Funds reported $11.6B of Cardinal Health stock for Q4 2018, down 20% quarter-over-quarter.
  • 131 funds opened new Cardinal Health positions in Q4 2018 and 88 closed out, a net change of +43 holders.
  • The largest Cardinal Health buyer in Q4 2018 was AQR Capital Management, an estimated $124M added.
  • The largest Cardinal Health seller in Q4 2018 was Barrow, Hanley, Mewhinney & Strauss, an estimated $454M sold.

Based on aggregated 13F filings for Q4 2018.